Enlivex ENLV
NASDAQ ENLV
$1.04 -0.07 (-6.31%)
At close: Sep 9, 2026 · 4:00 PM EDT

Enlivex (ENLV) Non Operating Income (2013 - 2025)

Enlivex (ENLV) posted Non Operating Income of $285000.0 for Q4 2025, down 19.03% on a QoQ basis from $352000.0 in Q3 2025, and down 37.5% year-over-year from $456000.0 in Q4 2024.

Analysis

Enlivex (ENLV) Non Operating Income (2013 - 2025) Analysis & Trends

Enlivex has reported Non Operating Income for 11 years, with the latest figure at $285000.0 in Q4 2025.

  • On a quarterly basis, Non Operating Income fell 37.5% year-over-year to $285000.0 in Q4 2025; TTM through Dec 2025 was $2.3 million, a 163.5% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 120.59% from the prior year.
  • Non Operating Income was $285000.0 for Q4 2025 at Enlivex, down from $352000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.2 million in Q2 2025, with the low at -$435000.0 in Q1 2023.
  • Average Non Operating Income over 3 years is $285750.0, with a median of $318500.0 recorded in 2025.
  • The largest YoY upside for Non Operating Income was 1200.0% in 2025 against a maximum downside of 37.5% in 2025.
  • Over 3 years, Non Operating Income stood at -$435000.0 in 2023, then surged by 204.83% to $456000.0 in 2024, then plunged by 37.5% to $285000.0 in 2025.
  • The last three Non Operating Income figures came in at $285000.0 (Q4 2025), $352000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -73.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 387.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 234.30 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -53.64 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Enlivex 3.17 Mn -2.59 Mn - 285,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 285,000.00
Sep 30, 2025 352,000.00
Jun 30, 2025 1.21 Mn
Dec 31, 2024 456,000.00
Sep 30, 2024 517,000.00
Jun 30, 2024 -110,000.00
Mar 31, 2024 11,000.00
Mar 31, 2023 -435,000.00
Sep 30, 2020 -166,000.00
Jun 30, 2020 -808,000.00
Mar 31, 2020 1.10 Mn
Sep 30, 2019 -270,000.00
Jun 30, 2019 -164,000.00
Mar 31, 2019 -303,000.00
Sep 30, 2018 139,000.00
Jun 30, 2018 317,000.00
Mar 31, 2018 -117,000.00
Dec 31, 2017 13,000.00
Sep 30, 2017 -4,000.00
Jun 30, 2017 21,000.00